FME - Fresenius Medical Care AG & Co. KGaA
XETRA
->
Healthcare
->
Medical Care Facilities
Bad Homburg,
Germany
Type: Equity
FME price evolution
FME
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $4062.26 | $4050.04 | $3636.51 | $3714.23 |
| Inventory | $2227.45 | $2216.4 | $2179.18 | $2303.9 |
| Total current assets | $8689.93 | $9282.68 | $8701.41 | $9054.21 |
| Long term investments | ||||
| Property, plant & equipment | $7261.84 | $7306.43 | $7454.02 | $7885.47 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $33896.2 | $34336.1 | $33929.81 | $35634.7 |
| Current liabilities | ||||
| Accounts payable | $783.68 | $725.18 | $762.07 | $753.12 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $5935.92 | $6203.6 | $6111.59 | $6619.33 |
| Long term debt | $10332.41 | $10509.37 | $10488.85 | $11067.1 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $19964.6 | $20428.74 | $20309.55 | $21628.14 |
| Shareholders' equity | ||||
| Retained earnings | $10871.95 | $11027.13 | $10921.69 | $10759.2 |
| Other shareholder equity | -$620.46 | -$798.77 | -$975.17 | -$424.13 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1079.06 | $911.01 | $925.13 | $746.85 |
| Short term investments | ||||
| Net receivables | $3857.16 | $3882.04 | $3769.23 | $3579.29 |
| Inventory | $2179.18 | $2296.21 | $2038.01 | $1895.31 |
| Total current assets | $8701.41 | $8203.45 | $7967.24 | $7275.31 |
| Long term investments | ||||
| Property, plant & equipment | $7454.02 | $8339.81 | $8551.47 | $8186.75 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $33929.81 | $35754.11 | $34366.56 | $31689.04 |
| Current liabilities | ||||
| Accounts payable | $762.07 | $813.25 | $736.07 | $731.99 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $6111.59 | $6467.31 | $7257.63 | $6159.64 |
| Long term debt | $10488.85 | $11175.67 | $10734.75 | $10683.23 |
| Total noncurrent liabilities | $10683.23 | |||
| Total debt | ||||
| Total liabilities | $20309.55 | $21764.66 | $21667.78 | $20473.96 |
| Shareholders' equity | ||||
| Retained earnings | $10921.69 | $10711.71 | $10826.14 | $10254.91 |
| Other shareholder equity | -$975.17 | -$388.47 | -$1311.64 | -$2205.34 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4724.52 | |||
| Cost of revenue | ||||
| Gross Profit | $1173.65 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $884 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $39.51 | |||
| Interest expense | -$129.76 | |||
| Net income | ||||
| Net income | $70.96 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $19454 | $19398.02 | $17618.69 | $17859.06 |
| Cost of revenue | ||||
| Gross Profit | $4925 | $5310.25 | $5077.03 | $5537.44 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $3678 | $3757.49 | $3217.76 | $3296.57 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $301 | $324.95 | $352.83 | $500.56 |
| Interest expense | -$214 | -$322.34 | -$254.4 | -$252.56 |
| Net income | ||||
| Net income | $499 | $673.4 | $969.31 | $1164.38 |
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $254.19 | -$68.37 | -$544.23 | -$447.73 |
| Financing activities | ||||
| Dividends paid | -$349.16 | -$328.62 | -$328.62 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1127.03 | -$289.66 | -$1858.53 | -$1112.88 |
| Effect of exchange rate | -$12.23 | -$4.51 | -$72.61 | -$48.56 |
| Change in cash and equivalents | -$315.35 | -$235.23 | $153.44 | $300.57 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$544.23 | -$734.73 | -$1196.23 | -$1334.94 |
| Financing activities | ||||
| Dividends paid | -$328.62 | -$395.56 | -$392.45 | -$351.17 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1858.53 | -$1617.36 | -$1024.38 | -$2664.03 |
| Effect of exchange rate | -$72.61 | -$23.16 | $131.23 | -$160.37 |
| Change in cash and equivalents | $153.44 | -$207.87 | $400.12 | $73.82 |
News
Fundamentals
| Market cap | $14.10B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 293.41M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.46 |
| Quick ratio | 1.09 |